Epidemiology, clinical features, and associated factors in 78 cases of lichen planus on black skin.


Journal

International journal of dermatology
ISSN: 1365-4632
Titre abrégé: Int J Dermatol
Pays: England
ID NLM: 0243704

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 29 12 2018
revised: 09 08 2019
accepted: 24 09 2019
pubmed: 21 10 2019
medline: 18 11 2020
entrez: 21 10 2019
Statut: ppublish

Résumé

The pathogenesis of lichen planus (LP) is mostly autoimmune, while psychological and infectious factors are recognized to trigger or aggravate the disease. An association with diabetes is reported. Our objective was to determine the epidemio-clinical characteristics of LP and its associated factors. This multicentric, prospective study was conducted over a 6-month period. The histopathology was only performed for atypical forms. Patients with a notion of drug intake before the rash were excluded. Anti-hepatitis C Virus (HCV) antibodies screening was systematical in case of mucosal damage. The data were analyzed using the SPSS IBM 20 software. The average age was 38 years. Women represented 84.6% (n = 66) of the studied population. The patients were married in 61.5%. Obesity or overweight status was noted in 41%. A marital or relational conflict was found in 25.6%. History of LP was reported in 24.4% (n = 19). Pruritus was found in 96.2%. The locations were as follows: skin (97.4%), mucous membranes (15.4%), and hair and nails (5.1%). Lesions were diffuse in 56.4%. The clinical forms were as follows: typical (52.6%), erythematosquamous (17%), warty (14.5%), pigmented (14.5%), and blaschkolinear (one case). Histopathology confirmed the diagnosis of LP in 91.4%. Blood sugar level was high in one case. Hepatitis B surface antigen (HBsAg) was positive in 3.03%. Anti-HIV and anti-HCV antibodies were negative. Lichen planus is a relatively rare disease in sub-Saharan Africa and is seen more in adults. The clinical manifestations are polymorphic, but the mucosal damage is rarely isolated.

Sections du résumé

BACKGROUND BACKGROUND
The pathogenesis of lichen planus (LP) is mostly autoimmune, while psychological and infectious factors are recognized to trigger or aggravate the disease. An association with diabetes is reported. Our objective was to determine the epidemio-clinical characteristics of LP and its associated factors.
METHODS METHODS
This multicentric, prospective study was conducted over a 6-month period. The histopathology was only performed for atypical forms. Patients with a notion of drug intake before the rash were excluded. Anti-hepatitis C Virus (HCV) antibodies screening was systematical in case of mucosal damage. The data were analyzed using the SPSS IBM 20 software.
RESULTS RESULTS
The average age was 38 years. Women represented 84.6% (n = 66) of the studied population. The patients were married in 61.5%. Obesity or overweight status was noted in 41%. A marital or relational conflict was found in 25.6%. History of LP was reported in 24.4% (n = 19). Pruritus was found in 96.2%. The locations were as follows: skin (97.4%), mucous membranes (15.4%), and hair and nails (5.1%). Lesions were diffuse in 56.4%. The clinical forms were as follows: typical (52.6%), erythematosquamous (17%), warty (14.5%), pigmented (14.5%), and blaschkolinear (one case). Histopathology confirmed the diagnosis of LP in 91.4%. Blood sugar level was high in one case. Hepatitis B surface antigen (HBsAg) was positive in 3.03%. Anti-HIV and anti-HCV antibodies were negative.
CONCLUSION CONCLUSIONS
Lichen planus is a relatively rare disease in sub-Saharan Africa and is seen more in adults. The clinical manifestations are polymorphic, but the mucosal damage is rarely isolated.

Identifiants

pubmed: 31630401
doi: 10.1111/ijd.14698
doi:

Substances chimiques

Hepatitis B Surface Antigens 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

137-142

Informations de copyright

© 2019 The International Society of Dermatology.

Références

McCartan BE, Healy CM. The reported prevalence of oral lichen planus: a review and critique. J Oral Pathol Med 2008; 37: 447-453.
Strobel M, Ndiaye B, Padonou-do Ango F, et al. Lichen plan au sénégal. Dakar Med 1979; 24: 159-166.
Shiohara T, Mizukawa Y, Takahashi R, et al. Pathomechanisms of lichen planus autoimmunity elicited by cross-reactive T cells. Curr Dir Autoimmun 2008; 10: 206-226.
Wilson DJ. Eczématous and pigmentary lichenoïd dermalis: atypical lichen planus: Preliminary report. Arch Derm Syphilol 1946; 54: 377-396.
Jones M, Hafsi W, El Fekih N, et al. Le lichen plan en Tunisie : à propos de 145 cas. Ann Dermatol Venerol 2012; 139: B175-B176.
Teclessou JN, Akakpo AS, Saka B, et al. Dermatoses lichénoïdes en milieu hospitalier à Lomé, Togo: une étude de 959 cas. Med Sante Trop 2018; 28: 261-264.
Hellgren L. The prevalence of lichen ruber planus in different geographical ar-eas in Sweden. Acta Derm Venereol 1970; 50: 374-80.
Sfia M, Benmously R, Badri T, et al. Lichen planus in Tunisia: a study about 61 patients. Dermatol Clin 2008; 28: 115.
Nanda A, Al-Ajmi HS, Al-Sabah H, et al. Childhood lichen planus: a report of 23 cases. Pediatr Dermatol 2001; 18: 1-4.
Bilgili SG, Karadag AS, Ozkol HU, et al. The prevalence of skin diseases among the geriatric patients in eastern Turkey. J Pak Med Assoc 2012; 62: 535-9.
Sawant NS, Vanjari NA, Khopkar U, et al. A study of depression and quality of life in patients of lichen planus. ScientificWorldJournal 2015; 2015: 817481.
Tawil MEL, Sediki N, Hassan H Psychobiological aspects of patients with lichen planus current. Psychiatry 2009; 16: 370-80.
Sarr A, Ly F, Manga M, et al. Dermatoses associées au diabète chez des patients sénégalais (étude prospective à propos de 140 patients). Rev CAMES-Série A 2012; 13: 128-132.
Nigam PK, Sharma L, Agrawal JK, et al. Glucose tolerance studies in lichen planus. Dermatologica 1987; 175: 284-287.
Grinspan D, Diaz J, Villapol LO, et al. Lichen rubber planus of buccal mucosa: its association with diabetes. Bull Soc Fr Dermatol Syphiligr 1966; 3: 898-899.
Bastos AS, Leite AR, Spin-Neto R, et al. Diabetes mellitus and oral mucosa alterations: prevalence and risk factors. Diabetes Res Clin Pract 2011; 92: 100-105.
Ponte E, Tabaj D, Maglione M, et al. Diabetes mellitus and oral disease. Acta Diabetol 2001; 38: 57-62.
Silverman S, Gorsky M, Lozada-Nur F, et al. A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1991; 72: 665-670.
Copeman PW, Tan RS, Timlin D. Familial lichen planus. another disease or distinct people? Br J Dermatol 1978; 98: 573-577.
Valsecchi R, Bontempelli M, di Landro A, et al. Familial lichen planus. Dermatologica 1990; 180: 166-168.
Singal A. Familial mucosal lichen planus in three successive generations. Int J Dermatol 2005; 44: 81-82.
Dogan B. Dermatological manifestations in hepatitis B surface antigen carriers in east region of Turkey. J Eur Acad Dermatol Venereol 2005; 19: 323-325.
Birkenfeld S, Dreiher J, Weitzman D, et al. A study on the association with hepatitis B and hepatitis C in 1557 patients with lichen planus. J Eur Acad Dermatol Venereol 2011; 25: 436-440.
Ibrahim HA, Baddour MM, Morsi MG, et al. Should we routinely check for hepatitis B and C in patients with lichen planus or cutaneous vasculitis? East Mediterr Health J 1999; 5: 71-78.
Daramola OO, George AO, Ogunbiyi AO. Hepatitis C virus and lichen planus in Nigerians: any relationship? Int J Dermatol 2002; 41: 217-219.
Lodi G, Pellicano R, Carrozzo M. Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis. Oral Dis 2010; 16: 601-612.
Figueiredo LC, Carrilho FJ, de Andrage HF, et al. Oral lichen planus and hepatitis C virus infection. Oral Dis 2002; 8: 42-46.
Daramola OO, Ogunbiyi AO, George AO. Evaluation of clinical types of cutaneous lichen planus in anti-hepatitis C virus seronegative and seropositive Nigerian patients. Int J Dermatol 2003; 42: 933-935.
Klanrit P, Thongprasom K, Rojanawatsirivej S, et al. Hepatitis C virus infection in Thai patients with oral lichen planus. Oral Dis 2003; 9: 292-297.
Lodi G, Giuliani M, Majorana A, et al. Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol 2004; 151: 1172-1181.
Friedrich RE, Heiland M, El-Moawen A, et al. Oral lichen planus in patients with chronic liver diseases. Infection 2003; 31: 383-386.
Bokor-Bratic M. Lack of evidence of hepatic disease in patients with oral lichen planus in Serbia. Oral Dis 2004; 10: 283-286.
Cunha KS, Manso AC, Cardoso AS, et al. Prevalence of oral lichen planus in Brazilian patients with HCV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 330-333.
Levy A, Le Cleach L. Lichen plan et dermatoses lichénoides. EMC - Dermatologie-Cosmétologie 2005; 3: 132-146.
Tickoo U, Bubna AK, Subramanyam S, et al. A clinicopathologic study of lichen planus at a tertiary health care centre in south India. Pigment Int 2016; 3: 96-101.
Kachhawa D, Kachhawa V, Kalla G, et al. A clinico-aetiological profile of 375 cases of lichen planus. Indian J Dermatol Venereol Leprol 1995; 61: 276-279.
Pecoraro V, Romano BE. Anal manifestations of lichen planus. Med Cutan Ibero Lat Am 1984; 12: 339-344.
Bhattacharya M, Kaur I, Kuma B. Lichen planus: a clinical and epidemiological study. J Dermatol 2000; 27: 576-582.
Gurusamy L, Selvaraj U. Clinicopathological Study of Lichen Planus in a Tertiary Care Center. Int J Sci Stud 2016; 4: 244-247.
Hammami F, Boudaya S, Masmoudi A, et al. Lichen plan pigmentogène : une série de 20 cas. Ann Dermatol Venereol 2017; 144: S224.
Ghosh A, Coondoo A. Lichen planus pigmentosus: the controversial consensus. Indian J Dermatol 2016; 61: 482-486.

Auteurs

Assane Diop (A)

Dermatology Hospital Institute of Social Hygiene (IHS) of Dakar, Dakar, Senegal.

Fatimata Ly (F)

Dermatology Hospital Institute of Social Hygiene (IHS) of Dakar, Dakar, Senegal.

Mame Tene Ndiaye (MT)

Dermatology Hospital Institute of Social Hygiene (IHS) of Dakar, Dakar, Senegal.

Birame Seck (B)

Dermatology Hospital Institute of Social Hygiene (IHS) of Dakar, Dakar, Senegal.

Amal El Omari (A)

Dermatology Hospital Aristide Le Dantec (HALD), Dakar, Senegal.

Astou Diouf (A)

Dermatology Hospital Institute of Social Hygiene (IHS) of Dakar, Dakar, Senegal.

Myriam Tajaoui (M)

Dermatology Hospital Institute of Social Hygiene (IHS) of Dakar, Dakar, Senegal.

Saer Diadie (S)

Dermatology Hospital Institute of Social Hygiene (IHS) of Dakar, Dakar, Senegal.

Boubacar Ahy Diatta (B)

Dermatology Hospital Aristide Le Dantec (HALD), Dakar, Senegal.

Maodo Ndiaye (M)

Dermatology Hospital Aristide Le Dantec (HALD), Dakar, Senegal.

Moussa Diallo (M)

Dermatology Hospital Aristide Le Dantec (HALD), Dakar, Senegal.

Suzanne Niang (S)

Dermatology Hospital Institute of Social Hygiene (IHS) of Dakar, Dakar, Senegal.

Assane Kane (A)

Dermatology Hospital Aristide Le Dantec (HALD), Dakar, Senegal.

Mame Thierno Dieng (M)

Dermatology Hospital Aristide Le Dantec (HALD), Dakar, Senegal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH